Sanjivani Paranteral Limited. (SANJIVIN.BO)
INR 236.8
(-1.04%)
INR 236.8
(-1.04%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 536.87 Million INR | 54.39% |
| 2022 | 352.42 Million INR | 16.02% |
| 2021 | 303.76 Million INR | 22.95% |
| 2020 | 247.07 Million INR | 54.31% |
| 2019 | 160.11 Million INR | -34.28% |
| 2018 | 243.61 Million INR | 36.57% |
| 2017 | 178.37 Million INR | -44.6% |
| 2016 | 321.97 Million INR | -72.08% |
| 2015 | 1.15 Billion INR | -13.14% |
| 2014 | 1.32 Billion INR | -16.1% |
| 2013 | 1.58 Billion INR | 4.27% |
| 2012 | 1.51 Billion INR | 1.17% |
| 2011 | 1.5 Billion INR | 3.86% |
| 2010 | 1.44 Billion INR | 3.8% |
| 2009 | 1.39 Billion INR | 34.64% |
| 2008 | 1.03 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 181.3 Million INR | 10.3% |
| 2024 Q1 | 164.37 Million INR | 27.78% |
| 2023 Q4 | 128.64 Million INR | -14.03% |
| 2023 FY | 544.1 Million INR | 54.39% |
| 2023 Q1 | 125.81 Million INR | 59.8% |
| 2023 Q2 | 140.02 Million INR | 11.3% |
| 2023 Q3 | 149.62 Million INR | 6.86% |
| 2022 FY | 352.42 Million INR | 16.02% |
| 2022 Q4 | 78.73 Million INR | -13.69% |
| 2022 Q3 | 91.21 Million INR | 9.48% |
| 2022 Q1 | 99.16 Million INR | 99.39% |
| 2022 Q2 | 83.31 Million INR | -15.99% |
| 2021 Q2 | 97.23 Million INR | 20.32% |
| 2021 Q4 | 49.73 Million INR | -34.54% |
| 2021 FY | 303.76 Million INR | 22.95% |
| 2021 Q1 | 80.81 Million INR | 18.71% |
| 2021 Q3 | 75.97 Million INR | -21.87% |
| 2020 Q3 | 47.78 Million INR | -41.71% |
| 2020 FY | 247.07 Million INR | 54.31% |
| 2020 Q1 | 49.23 Million INR | 41.01% |
| 2020 Q4 | 68.08 Million INR | 42.48% |
| 2020 Q2 | 81.97 Million INR | 66.5% |
| 2019 Q2 | 58.08 Million INR | 53.55% |
| 2019 Q4 | 34.91 Million INR | 19.2% |
| 2019 FY | 160.11 Million INR | -34.28% |
| 2019 Q1 | 37.82 Million INR | -18.58% |
| 2019 Q3 | 29.29 Million INR | -49.57% |
| 2018 Q3 | 84.13 Million INR | 46.89% |
| 2018 Q2 | 57.27 Million INR | 2.77% |
| 2018 Q1 | 55.73 Million INR | 43.81% |
| 2018 FY | 243.61 Million INR | 36.57% |
| 2018 Q4 | 46.45 Million INR | -44.78% |
| 2017 Q1 | 53.01 Million INR | -21.6% |
| 2017 FY | 178.37 Million INR | -44.6% |
| 2017 Q2 | 46.89 Million INR | -11.53% |
| 2017 Q3 | 40.92 Million INR | -12.73% |
| 2017 Q4 | 38.75 Million INR | -5.3% |
| 2016 Q1 | 98.44 Million INR | 58.83% |
| 2016 FY | 321.97 Million INR | -72.08% |
| 2016 Q4 | 67.62 Million INR | -30.62% |
| 2016 Q3 | 97.47 Million INR | 54.34% |
| 2016 Q2 | 63.15 Million INR | -35.85% |
| 2015 Q1 | 441.72 Million INR | 15.77% |
| 2015 FY | 1.15 Billion INR | -13.14% |
| 2015 Q4 | 61.98 Million INR | -74.02% |
| 2015 Q3 | 238.54 Million INR | -42.18% |
| 2015 Q2 | 412.56 Million INR | -6.6% |
| 2014 Q3 | 323.33 Million INR | 30.67% |
| 2014 FY | 1.32 Billion INR | -16.1% |
| 2014 Q4 | 381.55 Million INR | 18.01% |
| 2014 Q1 | 378.09 Million INR | -8.58% |
| 2014 Q2 | 247.44 Million INR | -34.56% |
| 2013 Q3 | 424.86 Million INR | 13.83% |
| 2013 Q4 | 413.59 Million INR | -2.65% |
| 2013 FY | 1.58 Billion INR | 4.27% |
| 2013 Q1 | 370.87 Million INR | -0.37% |
| 2013 Q2 | 373.23 Million INR | 0.64% |
| 2012 Q2 | 358.89 Million INR | -6.14% |
| 2012 FY | 1.51 Billion INR | 1.17% |
| 2012 Q1 | 382.35 Million INR | 0.12% |
| 2012 Q4 | 372.25 Million INR | 3.72% |
| 2012 Q3 | 358.89 Million INR | 0.0% |
| 2011 Q3 | 381.47 Million INR | 0.0% |
| 2011 FY | 1.5 Billion INR | 3.86% |
| 2011 Q4 | 381.9 Million INR | 0.11% |
| 2010 FY | 1.44 Billion INR | 3.8% |
| 2009 FY | 1.39 Billion INR | 34.64% |
| 2008 FY | 1.03 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 10.48 Million INR | -5018.162% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 96.041% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 48.809% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -34.141% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -45.028% |
| Sunil Healthcare Limited | 901.91 Million INR | 40.475% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -2820.636% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.046% |
| Zenith Healthcare Limited | 144.71 Million INR | -270.98% |
| Patidar Buildcon Limited | 2.3 Million INR | -23161.325% |
| Roopa Industries Limited | 715.53 Million INR | 24.969% |
| Smruthi Organics Limited | 1.27 Billion INR | 57.94% |
| Trident Lifeline Limited | 446.28 Million INR | -20.298% |
| Bacil Pharma Limited | - INR | -Infinity% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -255.259% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | -11.907% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -20.35% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 20.204% |
| PANJON LTD. | 125.52 Million INR | -327.714% |
| Tyche Industries Limited | 696.83 Million INR | 22.956% |
| Trimurthi Limited | 42.23 Million INR | -1171.063% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 91.702% |
| Crestchem Limited | 212.56 Million INR | -152.572% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -9569.874% |
| Zenlabs Ethica Limited | 585.63 Million INR | 8.326% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 57.191% |
| ANG Lifesciences India Limited | 1.46 Billion INR | 63.256% |
| Parmax Pharma Limited | 154.24 Million INR | -248.068% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 84.58% |
| Deccan Health Care Limited | 597.28 Million INR | 10.115% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 28.007% |
| Norris Medicines Limited | 56.35 Million INR | -852.641% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 88.418% |
| Veerhealth Care Limited | 142.13 Million INR | -277.722% |
| Makers Laboratories Limited | 1.03 Billion INR | 48.26% |
| Lactose (India) Limited | 1.13 Billion INR | 52.86% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -35.43% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 69.204% |
| Mercury Laboratories Limited | 755.59 Million INR | 28.947% |
| Gennex Laboratories Limited | 867.14 Million INR | 38.087% |
| PRAVEG LIMITED | 915.96 Million INR | 41.387% |
| Denis Chem Lab Limited | 1.67 Billion INR | 68.009% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 82.522% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 62.183% |
| Colinz Laboratories Limited | 70.29 Million INR | -663.73% |
| Godavari Drugs Limited | 1.56 Billion INR | 65.742% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -47920.696% |
| Zenotech Laboratories Limited | 368.08 Million INR | -45.854% |
| Panchsheel Organics Limited | 1.05 Billion INR | 48.976% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 57.356% |
| Vivanza Biosciences Limited | 278.89 Million INR | -92.502% |
| Phaarmasia Limited | 305.93 Million INR | -75.487% |
| Bharat Parenterals Limited | 2.59 Billion INR | 79.304% |
| Medi-Caps Limited | 265.63 Million INR | -102.109% |
| DECIPHER LABS LIMITED | 362.75 Million INR | -47.999% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 68.386% |
| BDH Industries Limited | 858.31 Million INR | 37.45% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -421.852% |
| Coral Laboratories Limited | 836.6 Million INR | 35.827% |
| Concord Drugs Limited | 449.24 Million INR | -19.505% |
| Beryl Drugs Limited | 271.24 Million INR | -97.927% |
| Evoq Remedies Limited | 63.09 Million INR | -750.961% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 73.433% |
| Transchem Limited | 4.09 Million INR | -12994.427% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -253.493% |
| Parnax Lab Limited | 1.88 Billion INR | 71.551% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -96.679% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 47.538% |
| Cian Healthcare Limited | 616.95 Million INR | 12.98% |
| Trinity League India Limited | 2.95 Million INR | -18099.03% |
| Syschem (India) Limited | 2.33 Billion INR | 77.011% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 65.457% |
| Auro Laboratories Limited | 526.99 Million INR | -1.874% |